Product Details for ANDA 214302
SELEXIPAG (SELEXIPAG)
0.2MG
Marketing Status: Discontinued
0.4MG
Marketing Status: Discontinued
0.6MG
Marketing Status: Discontinued
0.8MG
Marketing Status: Discontinued
1MG
Marketing Status: Discontinued
1.2MG
Marketing Status: Discontinued
1.4MG
Marketing Status: Discontinued
1.6MG
Marketing Status: Discontinued
0.2MG
Marketing Status: Discontinued
Active Ingredient: SELEXIPAG
Proprietary Name: SELEXIPAG
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.2MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A214302
Product Number: 001
Approval Date: Dec 21, 2022
Applicant Holder Full Name: ZYDUS WORLDWIDE DMCC
Marketing Status: Discontinued
Patent and Exclusivity Information
SELEXIPAG (SELEXIPAG)
Proprietary Name: SELEXIPAG
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.2MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A214302
Product Number: 001
Approval Date: Dec 21, 2022
Applicant Holder Full Name: ZYDUS WORLDWIDE DMCC
Marketing Status: Discontinued
Patent and Exclusivity Information
0.4MG
Marketing Status: Discontinued
Active Ingredient: SELEXIPAG
Proprietary Name: SELEXIPAG
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.4MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A214302
Product Number: 002
Approval Date: Dec 21, 2022
Applicant Holder Full Name: ZYDUS WORLDWIDE DMCC
Marketing Status: Discontinued
Patent and Exclusivity Information
SELEXIPAG (SELEXIPAG)
Proprietary Name: SELEXIPAG
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.4MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A214302
Product Number: 002
Approval Date: Dec 21, 2022
Applicant Holder Full Name: ZYDUS WORLDWIDE DMCC
Marketing Status: Discontinued
Patent and Exclusivity Information
0.6MG
Marketing Status: Discontinued
Active Ingredient: SELEXIPAG
Proprietary Name: SELEXIPAG
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.6MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A214302
Product Number: 003
Approval Date: Dec 21, 2022
Applicant Holder Full Name: ZYDUS WORLDWIDE DMCC
Marketing Status: Discontinued
Patent and Exclusivity Information
SELEXIPAG (SELEXIPAG)
Proprietary Name: SELEXIPAG
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.6MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A214302
Product Number: 003
Approval Date: Dec 21, 2022
Applicant Holder Full Name: ZYDUS WORLDWIDE DMCC
Marketing Status: Discontinued
Patent and Exclusivity Information
0.8MG
Marketing Status: Discontinued
Active Ingredient: SELEXIPAG
Proprietary Name: SELEXIPAG
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.8MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A214302
Product Number: 004
Approval Date: Dec 21, 2022
Applicant Holder Full Name: ZYDUS WORLDWIDE DMCC
Marketing Status: Discontinued
Patent and Exclusivity Information
SELEXIPAG (SELEXIPAG)
Proprietary Name: SELEXIPAG
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 0.8MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A214302
Product Number: 004
Approval Date: Dec 21, 2022
Applicant Holder Full Name: ZYDUS WORLDWIDE DMCC
Marketing Status: Discontinued
Patent and Exclusivity Information
1MG
Marketing Status: Discontinued
Active Ingredient: SELEXIPAG
Proprietary Name: SELEXIPAG
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A214302
Product Number: 005
Approval Date: Dec 21, 2022
Applicant Holder Full Name: ZYDUS WORLDWIDE DMCC
Marketing Status: Discontinued
Patent and Exclusivity Information
SELEXIPAG (SELEXIPAG)
Proprietary Name: SELEXIPAG
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A214302
Product Number: 005
Approval Date: Dec 21, 2022
Applicant Holder Full Name: ZYDUS WORLDWIDE DMCC
Marketing Status: Discontinued
Patent and Exclusivity Information
1.2MG
Marketing Status: Discontinued
Active Ingredient: SELEXIPAG
Proprietary Name: SELEXIPAG
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1.2MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A214302
Product Number: 006
Approval Date: Dec 21, 2022
Applicant Holder Full Name: ZYDUS WORLDWIDE DMCC
Marketing Status: Discontinued
Patent and Exclusivity Information
SELEXIPAG (SELEXIPAG)
Proprietary Name: SELEXIPAG
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1.2MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A214302
Product Number: 006
Approval Date: Dec 21, 2022
Applicant Holder Full Name: ZYDUS WORLDWIDE DMCC
Marketing Status: Discontinued
Patent and Exclusivity Information
1.4MG
Marketing Status: Discontinued
Active Ingredient: SELEXIPAG
Proprietary Name: SELEXIPAG
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1.4MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A214302
Product Number: 007
Approval Date: Dec 21, 2022
Applicant Holder Full Name: ZYDUS WORLDWIDE DMCC
Marketing Status: Discontinued
Patent and Exclusivity Information
SELEXIPAG (SELEXIPAG)
Proprietary Name: SELEXIPAG
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1.4MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A214302
Product Number: 007
Approval Date: Dec 21, 2022
Applicant Holder Full Name: ZYDUS WORLDWIDE DMCC
Marketing Status: Discontinued
Patent and Exclusivity Information
1.6MG
Marketing Status: Discontinued
Active Ingredient: SELEXIPAG
Proprietary Name: SELEXIPAG
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1.6MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A214302
Product Number: 008
Approval Date: Dec 21, 2022
Applicant Holder Full Name: ZYDUS WORLDWIDE DMCC
Marketing Status: Discontinued
Patent and Exclusivity Information
Proprietary Name: SELEXIPAG
Dosage Form; Route of Administration: TABLET; ORAL
Strength: 1.6MG
Reference Listed Drug: No
Reference Standard: No
TE Code:
Application Number: A214302
Product Number: 008
Approval Date: Dec 21, 2022
Applicant Holder Full Name: ZYDUS WORLDWIDE DMCC
Marketing Status: Discontinued
Patent and Exclusivity Information